Free New Drug Intelligence Platform
Connecting Disparate Data
71,890
Drugs & Biologics
44,741
Targets
360,184
Organizations
796,598
Clinical Trials
62,480,902
Literatures
13,753,973
Patents
Access to drugs, clinical trials, news, literature and patents in one search
Are you experiencing the following problems？
- Hard to get quality clinical trial data
- Difficult to find potential partnerships or acquisition targets
- Not enough reliable data to estimate the development prospects of new drug pipelines
- Spent too much time and money investigating the technical progress of competitors
A new drug intelligence platform that can solve all the problems as much as possible.
Why Synapse?
Stay informed throughout the drug discovery and development lifecycle
Synapse integrates and standardizes more than 67,000+ drugs from early-stage discovery to approval, covering 44,000+ targets and 13,000+ diseases, to help you make confident, timely R&D decisions. Identify gaps in the market, find key players, and accelerate your drug development strategy.
Find the best partnerships
With Synapse, you can track more than 320,000+ life science organizations to help you make informed decisions on potential partnerships or acquisition targets. In the company profile, gain insight on a company's top focus areas, explore their drug pipeline, view their investment history, and more.
Anticipate potential threats and identify whitespace
Synapse connects the dots across a plethora of datasets, allowing innovators to gain a 360-degree view of a company, market, or technology area and uncover the gaps while mitigating risk. Plus, with features such as email alerts you can keep a pulse on the latest research.
Gain insights on drugs, targets, indications, or organizations of interest
Using Dashboards, Synapse allows you to uncover relationships between entities, gain competitor insights, and identify emerging trends. Synapse's Dashboards are fully customizable and provide instant visualizations of critical life sciences data, enabling both R&D and business development decision-makers to easily explore technology landscapes.